Your browser doesn't support javascript.
loading
Mortality and glycemic control among patients with diabetes mellitus and uterine or ovarian cancer.
Kusne, Yael N; Kosiorek, Heidi E; Buras, Matthew R; Coppola, Kyle E; Verona, Patricia M; Cook, Curtiss B; Karlin, Nina J.
Afiliação
  • Kusne YN; Department of Internal Medicine, Mayo Clinic Hospital, Phoenix, AZ 85054, USA.
  • Kosiorek HE; Biostatistics, Mayo Clinic Hospital, Phoenix, AZ 85054, USA.
  • Buras MR; Biostatistics, Mayo Clinic Hospital, Phoenix, AZ 85054, USA.
  • Coppola KE; Mayo Clinic Cancer Center, Mayo Clinic Hospital, Phoenix, AZ 85054, USA.
  • Verona PM; Enterprise Technology Services, Mayo Clinic Hospital, Phoenix, AZ 85054, USA.
  • Cook CB; Division of Endocrinology, Mayo Clinic Hospital, Phoenix, AZ 85054, USA.
  • Karlin NJ; Mayo Clinic Cancer Center, Mayo Clinic Hospital, Phoenix, AZ 85054, USA.
Future Sci OA ; 7(3): FSO670, 2020 Dec 18.
Article em En | MEDLINE | ID: mdl-33552546
ABSTRACT

AIM:

To evaluate associations between survival and glycemic control in age-matched patients with endometrial or ovarian cancer, with/without diabetes mellitus (DM). PATIENTS &

METHODS:

Patients with newly diagnosed ovarian or endometrial cancer with and without DM were compared.

RESULTS:

The study included 84 patients with ovarian cancer (28, DM); 96 with endometrial cancer (48 with, 48 without DM). DM patients did not have worse overall or progression-free survival than non-DM patients. Glycemic control was not associated with either cancer.

CONCLUSION:

There was no association between DM and survival for patients with uterine or ovarian cancer. In addition, there was no association between uterine and ovarian cancer and glycemic control. Additional studies to confirm these observations in larger populations are required.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article